This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Oct 24;369(17):1579-81.

doi: 10.1056/NEJMp1310102. Epub 2013 Aug 31.

The randomized registry trial--the next disruptive technology in clinical research?

Michael S Lauer¹, Ralph B D'Agostino Sr

Affiliations

Affiliation

¹ From the Office of the Director, Division of Cardiovascular Sciences, the National Heart, Lung, and Blood Institute, Bethesda, MD (M.S.L.); and the Mathematics and Statistics Department, Boston University, and the Harvard Clinical Research Institute - both in Boston (R.B.D.).

PMID: 23991657
DOI: 10.1056/NEJMp1310102

The randomized registry trial--the next disruptive technology in clinical research?

Michael S Lauer et al. N Engl J Med. 2013.

. 2013 Oct 24;369(17):1579-81.

doi: 10.1056/NEJMp1310102. Epub 2013 Aug 31.

Authors

Michael S Lauer¹, Ralph B D'Agostino Sr

Affiliation

¹ From the Office of the Director, Division of Cardiovascular Sciences, the National Heart, Lung, and Blood Institute, Bethesda, MD (M.S.L.); and the Mathematics and Statistics Department, Boston University, and the Harvard Clinical Research Institute - both in Boston (R.B.D.).

PMID: 23991657
DOI: 10.1056/NEJMp1310102

No abstract available

PubMed Disclaimer

Comment in

The randomized registry trial.
Baker SG, Kramer BS, Lindeman KS. Baker SG, et al. N Engl J Med. 2014 Feb 13;370(7):681-2. doi: 10.1056/NEJMc1315677. N Engl J Med. 2014. PMID: 24521130 No abstract available.

Similar articles

Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?
Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, Wilton SB, Williamson T, Gill S, Drogos LL, Smith EE, Vohra S, Hill MD, Thabane L; 2016 Symposium on Registry-Based Randomized Controlled Trials in Calgary. Li G, et al. J Clin Epidemiol. 2016 Dec;80:16-24. doi: 10.1016/j.jclinepi.2016.08.003. Epub 2016 Aug 20. J Clin Epidemiol. 2016. PMID: 27555082 Review.
The randomized registry trial.
Baker SG, Kramer BS, Lindeman KS. Baker SG, et al. N Engl J Med. 2014 Feb 13;370(7):681-2. doi: 10.1056/NEJMc1315677. N Engl J Med. 2014. PMID: 24521130 No abstract available.
The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics.
Dunn AG, Bourgeois FT, Murthy S, Mandl KD, Day RO, Coiera E. Dunn AG, et al. Clin Pharmacol Ther. 2012 Apr;91(4):685-91. doi: 10.1038/clpt.2011.279. Epub 2012 Feb 29. Clin Pharmacol Ther. 2012. PMID: 22378152
Randomized controlled trials and comparative effectiveness research.
Hahn OM, Schilsky RL. Hahn OM, et al. J Clin Oncol. 2012 Dec 1;30(34):4194-201. doi: 10.1200/JCO.2012.42.2352. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071239 Review.
Commentary: How the debate about comparative effectiveness research should impact the future of clinical trials.
Lauer MS. Lauer MS. Stat Med. 2012 Nov 10;31(25):3051-3. doi: 10.1002/sim.5400. Stat Med. 2012. PMID: 23055180

See all similar articles

Cited by

Learning health care systems: Highly needed but challenging.
Wouters RHP, van der Graaf R, Voest EE, Bredenoord AL. Wouters RHP, et al. Learn Health Syst. 2020 Jan 13;4(3):e10211. doi: 10.1002/lrh2.10211. eCollection 2020 Jul. Learn Health Syst. 2020. PMID: 32685681 Free PMC article.
Accrual of adolescents and young adults with cancer to clinical trials.
Hay AE, Rae C, Fraser GA, Meyer RM, Abbott LS, Bevan S, McBride ML, Cuvelier GD, McKillop S, Barr RD. Hay AE, et al. Curr Oncol. 2016 Apr;23(2):e81-5. doi: 10.3747/co.23.2925. Epub 2016 Apr 13. Curr Oncol. 2016. PMID: 27122988 Free PMC article. No abstract available.
Intrathecal Drug Delivery Systems (IDDS): The Implantable Systems Performance Registry (ISPR).
Konrad PE, Huffman JM, Stearns LM, Plunkett RJ, Grigsby EJ, Stromberg EK, Roediger MP, Wells MD, Weaver TW. Konrad PE, et al. Neuromodulation. 2016 Dec;19(8):848-856. doi: 10.1111/ner.12524. Epub 2016 Oct 12. Neuromodulation. 2016. PMID: 27730704 Free PMC article.
The year of transparency: measuring quality of cardiac care.
Eindhoven DC, Wierda E, de Bruijne MC, Amoroso G, de Mol BAJM, Umans VAWM, Schalij MJ, Borleffs CJW. Eindhoven DC, et al. Neth Heart J. 2015 Sep;23(10):457-465. doi: 10.1007/s12471-015-0739-9. Neth Heart J. 2015. PMID: 26272243 Free PMC article.
Registry randomised trials: a methodological perspective.
Doherty DA, Tong SYC, Reilly J, Shrapnel J, McDonald S, Ahern S, Harris I, Tam CS, Brennan AL, Hodgson C, Wilcox L, Balagurunathan A, Butcher BE, Reid CM. Doherty DA, et al. BMJ Open. 2023 Mar 1;13(3):e068057. doi: 10.1136/bmjopen-2022-068057. BMJ Open. 2023. PMID: 36858472 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov